Region-Dependent Role of Cell-Penetrating Peptides in Insulin Absorption Across the Rat Small Intestinal Membrane
Journal Title: The AAPS Journal - Year 2015, Vol 17, Issue 6
Abstract
We have reported that the cell-penetrating peptide (CPP) penetratin acts as a potential absorption enhancer in oral insulin delivery systems and that this action occurs through noncovalent intermolecular interactions. However, the region-dependent role of CPPs in intestinal insulin absorption has not been clarified. To identify the intestinal region where CPPs have the most effect in increasing insulin absorption, the region-dependent action of penetratin was investigated using in situ closed intestinal loops in rats. The order of the insulin area under the insulin concentration–time curve (AUC) increase effect by l -penetratin was ileum > jejunum > duodenum > colon. By contrast, the AUC order after coadministration of insulin with d -penetratin was colon > duodenum ≥ jejunum and ileum. We also compared the effects of the l - and d -forms of penetratin, R8, and PenetraMax on ileal insulin absorption. Along with the CPPs used in this study, l - and d -PenetraMax produced the largest insulin AUCs. An absorption study using ilea pretreated with CPPs showed that PenetraMax had no irreversible effect on the intestinal epithelial membrane. The degradation of insulin in the presence of CPPs was assessed in rat intestinal enzymatic fluid. The half-life (t1/2) of insulin increased from 14.5 to 23.7 and 184.7 min in the presence of l - and d -PenetraMax, respectively. These enzymatic degradation-resistant effects might contribute partly to the increased ileal absorption of insulin induced by d -PenetraMax. In conclusion, this study demonstrated that the ability of the l - and d -forms of penetratin to increase intestinal insulin absorption was maximal in the ileum and the colon, respectively, and that d -PenetraMax is a powerful but transient enhancer of oral insulin absorption.
Authors and Affiliations
El-Sayed Khafagy, Ruisha Iwamae, Noriyasu Kamei, Mariko Takeda-Morishita
Keywords
Related Articles
- EP ID EP681023
- DOI 10.1208/s12248-015-9804-y
- Views 36
- Downloads 0
Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials
Extensive research over the past half century has shown that curcumin (diferuloylmethane), a component of the golden spice turmeric (Curcuma longa), can modulate multiple cell signaling pathways. Extensive clinical trial...
Prediction of Modified Release Pharmacokinetics and Pharmacodynamics from In Vitro, Immediate Release, and Intravenous Data
The aim of this study was to demonstrate the value of mechanistic simulations in gaining insight into the behaviors of modified release (MR) formulations in vivo and to use the properly calibrated models for prediction o...
Similarities and Differences of International Guidelines for Bioequivalence: an Update of the Brazilian Requirements
Ophthalmic drug design based on the metabolic activity of the eye: Soft drugs and chemical delivery systems
Despite its apparent easy accessibility, the eye is, in fact, well protected against the absorption of foreign materials, including therapeutic agents, by the eyelids, by the tearflow, and by the permeability barriers im...
Nanomedicine Drug Development: A Scientific Symposium Entitled “Charting a Roadmap to Commercialization”
The use of nanotechnology in medicine holds great promise for revolutionizing a variety of therapies. The past decade witnessed dramatic advancements in scientific research in nanomedicines, although significant challeng...